Consumption of GLs and the prevention of type II diabetes
Descriptive statistics tools and chemical composition were used to study the strength of the link between seed consumption and the prevention of type II diabetes (figure 9), high blood pressure, obesity and stroke (figure 10). Strong and negative correlations were obtained with the most consumed GLs varieties. While strong and positive correlations were found with the least consumed GLs varieties. In vivo, in vitro, and in silico studies have confirmed the correlations between the GLs’ consumption and the prevention of the aforementioned diseases. Correlations regarding antidiabetic properties agree with the works of Flight & Clinton [63], Remond & Warland [64], and Mune et al. [26]. Works which highlight the positive impacts of GLs’ consumption (soybeans, cowpeas and Bambara groundnut) in the prevention of type II diabetes. Indeed, GLs administered (during a meta-analysis) alone or as part of low glycaemic index or high fibre diets improve the main markers of glycaemic control, namely blood levels of glycated hemoglobin or HbA1c or fructosamine, and fasting blood sugar [63,64]. These studies have shown that consuming GLs can optimise medium-to long-term glycaemic control by enhancing the effects of insulin.
In addition, the significant protein content in these various GLs widely justifies their nutritional and therapeutic values. Indeed, GLs are known for their high protein content, due to these proteins fulfil various biological functions. Certain peptides mainly have a metabolic role (enzymes, oxygen transport, etc.), or a defensive role (enzyme inhibitors, lectins, entomo-toxic, antifungal, antimicrobial proteins). Numerous studies on peptides derived from the hydrolysis of dietary proteins have revealed their importance in the regulation of type II diabetes [26,65,66]. Other studies have also shown that a diet rich in plant foods, including GLs, reduces the risk of developing type 2 diabetes, improves blood sugar levels, and controls blood lipid constants [67]. These studies confirm the antidiabetic effects of the studied GLs. These effects can also be justified by the presence in soybean, Bambara groundnut, or cowpea of bioactive proteins, peptides, or amino acids endowed with an inhibitory property of Dipeptidyl peptidase-IV [26].
Diabetes is associated with hyperglycaemia and hyperlipidaemia-induced oxidative stress. Oxidative stress is caused by an imbalance in the production and detoxification of reactive oxygen species (ROS) in biological systems [68]. Many diabetes-related complications are caused by oxidative stress, which activates major signalling pathways and transcriptional factors (e.g., activating protein (AP)-1 and Kelch-like ECH-associating protein 1-NFE2-related factor 2 (Keap1-Nrf2)) [68–70]. As a result, there is a compelling case for using therapeutic antioxidants to treat and prevent diabetic complications. In view of their biological potential, polyphenolic compounds, particularly flavonoids, could play a fundamental role in antioxidant mechanisms. In addition, chronic nonspecific inflammation, including inflammatory cytokine expression primarily from adipose tissue, occurs during the development of type 2 diabetes. As a result, the reported anti-inflammatory properties of anthocyanins may be critical for the treatment of this disease [68–70]. These compounds may thus contribute considerably to combating oxidative stress, thus improving the control of diabetes.
Furthermore, dietary fibre regulates blood sugar, lowering hyperglycaemia and hyperinsulinemia, which is especially important in diabetic and pre-diabetic patients [29,71]. Short-chain fatty acids (SCFAs), also known as volatile fatty acids, are produced when fermentable fibres are fermented. SCFAs play a role in a variety of health-promoting physiological processes, including blood sugar stabilisation via pancreatic insulin release and hepatic control of glycogen breakdown. These volatile fatty acids also increase the expression of glucose transporter genes in the intestinal mucosa, which controls glucose absorption [28,29,71,72].
These correlations provide the arguments leading to the valorisation of GLs in general and of those underutilised in particular in the formulation of functional foods with the above-mentioned bioactive properties.
Consumption of GLs and the prevention of high blood pressure
The above-mentioned chemical compounds and correlations regarding GL consumption and the blood pressure control are in agreement with the works of He et al. [73], Koné et al. [30], Arise et al. [74], and Mune et al. [26]. In the studies by Arise et al.; and Mune et al. [26,74], Bambara groundnut protein hydrolysates were obtained using different proteases (subtilisin, trypsin, and pepsin) and their peptide fractions (molecular weight: 10, 5, 3, and 1 kDa) showed antihypertensive and antioxidant properties. The results showed the hydrolysates exhibited strong inhibitory activities against Angiotensin-Converting Enzyme (ACE), anti-free radical activity with DPPH, and the metal chelating power. In addition, the work of He et al. [73] showed that soy protein supplementation resulted in a reduction in systolic and diastolic blood pressure. Antihypertensive effects in humans have not been proven for most of the peptides obtained by processing food proteins. In recent years, it has been reported that the biologically active peptides from foods might have beneficial effects on human health, especially as immunomodulating, antihypertensive, and osteoprotective substances [26,75].
The probable antihypertensive properties of these GLs would also be justified by the involvement of protein hydrolysates (peptides), endowed with bioactive properties, in the regulatory mechanisms of the renin-angiotensin system. This is in addition to the inhibition of ACE through the regulation of vascular functions (vasodilation and vasoconstriction) [27,76]. In addition, the antioxidant potential of protein hydrolysates would explain the antihypertensive properties of studied GLs. Indeed, the relationship between antioxidant and antihypertensive activity is that antioxidant deficiency leads to increased blood pressure (hypertension). Thus, one of the main adverse effects of angiotensin II is the increase in the formation of reactive oxygen species [77]. In addition, the oxidation of lipids, specifically low-density lipoproteins (LDL), contributes to the development of arteriosclerosis. In many cases, this pathology accompanies and promotes the state of hypertension [77].
In addition, legumes are rich in potassium, magnesium and other minerals that have a positive impact on the maintenance and regulation of blood pressure. Indeed, epidemiological, observational, and controlled clinical trials (in the USA) show that increased sodium intake is associated with higher blood pressure [64,78]. Reducing sodium intake in hypertensive patients, particularly in salt-sensitive patients, significantly lowers blood pressure by 4-6/2 to 3 mm Hg [64,78]. Similarly, a significant reduction in blood pressure with increased dietary K+ intake. High dietary calcium levels are not only associated with lower blood pressure, but also with a reduced risk of developing hypertension [64,78].
The antihypertensive potential of GLs would also be justified by their polyphenol compounds. Numerous studies, including the present one, have shown that polyphenolic compounds, mainly flavonoids, are endowed with free radical scavenging properties (DPPH) and a strong ferric reducing antioxidant power (FRAP). These antioxidant properties have an important place in the mechanisms of blood pressure regulation [77].
Similarly, the potential antihypertensive properties of these GLs are also explained by the presence of dietary fibre in remarkable quantities. Indeed, the consumption of dietary fibre contributes to reducing the risk of systolic and diastolic hypertension [79]. Short-chain fatty acids (SCFAs), produced during fibre fermentation, are involved in many physiological processes that promote good blood pressure management. These fatty acids decrease hepatic cholesterol synthesis and reduce blood levels of LDL-cholesterol and triglycerides responsible for atherosclerosis [29,71].
All of these studies, including the present work, suggest that an increased intake of soybean, Bambara groundnut, and cowpea protein (and their hydrolysates) may play an important role in the prevention and/or treatment of type II diabetes and high blood pressure (figure 10).
Consumption of GLs and the prevention of obesity and stroke
Strong correlations were obtained between the GLs’ consumption and the prevention of obesity and stroke. Numerous studies suggest that soy protein and its isoflavones may play a beneficial role in weight management. Several nutritional intervention studies in animals and humans indicate that consumption of soybean and BB protein reduces body weight and fat mass in addition to lowering plasma cholesterol and triglycerides [35,36]. Several potential mechanisms by which proteins from these legumes can reduce body fat and blood lipids are discussed and include a wide range of biochemical and molecular activities that favourably affect fatty acid metabolism and cholesterol homeostasis (figure 10) [35,36]. Protein hydrolysates derived from GLs could be used to support their potential therapeutic properties in the prevention of cardiometabolic diseases. In some in vitro and in vivo studies, these enzymatic hydrolysates demonstrated hypocholesterolaemia and hypolipidemic activity related to LDL-cholesterol control. Indeed, it has been proposed that soy proteins can reduce obesity by modulating the expression of SREBPs (sterol regulatory element binding proteins), a family of transcription factors that regulates many genes involved in fatty acid and cholesterol synthesis [36,80].
Lipids play an important role in the proper functioning of the body (storage, structural and functional properties). Muench et al. [81] suggest that GLs may be beneficial for cardiovascular health and general health due to their high content of polyunsaturated fatty acids and low content of saturated fatty acids [21]. Both n−6 and n−3 polyunsaturated fatty acids have been associated with lower cardiovascular risk. Within the n−6 series, linoleic acid seems to decrease cardiovascular risk. Long-chain fatty acids (eicosapentaenoic and docosahexaenoic acids) in the n3 series are associated with lower risk, particularly for fatal coronary outcomes, whereas the role of linolenic acid is less clear [82].
Phenolic compounds constitute a class of organic molecules that arouse a great deal of interest due to their beneficial effects on health (antimicrobial properties, antioxidant capacities) [58,69,83]. Indeed, their role as a natural antioxidant is arousing growing interest in the prevention and treatment of cancerous, inflammatory, cardiovascular, and neurodegenerative diseases [58,69]. The presence of these polyphenolic compounds explains the use in traditional medicine of GLs as a cure for the prevention of certain metabolic and neurodegenerative diseases (Bambara groundnuts, particularly as shown in table 2). Recent in vitro studies have also shown that polyphenolic compounds, in particular flavonoids, have anti-amyloid and antidiabetic properties.
The GLs' anti-obesity properties could be explained by the antioxidant potential of proteins, protein hydrolysates, and/or polyphenolic compounds. Obesity is defined by an abdominal visceral accumulation of white adipose tissue, which causes chronic low-grade inflammation and oxidative stress [84]. Obesity and its associated pathologies are thought to be linked by oxidative stress. Oxidative stress has been shown to stimulate preadipocyte proliferation and differentiation, as well as the growth of mature adipocytes [84,85].
The abundant presence of dietary fibre, particularly in the BB cultivars, may justify the use of this GLs in traditional medicine. Dietary fibre, indeed, lowers total cholesterol levels of low-density lipoprotein (LDL), which may lower the risk of cardiovascular disease. The unique physical and chemical properties of dietary fibre that provide early signals of satiety as well as an enhanced and prolonged feeling of fullness [29,71] explain its role in the regulation of energy consumption and the development of obesity.